| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 2 |
| 1 | TACROLIMUS | 2 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 3 | TACROLIMUS OINTMENT 0.1% | 2 |
| 4 | ACETAMINOPHEN | 1 |
| 5 | ACETAMINOPHEN 500MG | 1 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 7 | AMLODIPINE | 1 |
| 8 | ANTACID | 1 |
| 9 | ANTI ITCH | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 1 | SOTORASIB | 1 | 0.0003 |
| 2 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 1 | 0.0001 |
| 3 | CLOBETASOL PROPIONATE | 1 | 0.0001 |
| 4 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 1 | 0.0001 |
| 5 | PRAVASTATIN SODIUM | 1 | 0.0000 |
| 6 | DURVALUMAB | 1 | 0.0000 |
| 7 | SENNOSIDES | 1 | 0.0000 |
| 8 | CYCLOBENZAPRINE | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Opioid Agonist [EPC] | 2 | 0.0000 |
| 7 | Vitamin D [EPC] | 1 | 0.0000 |
| 8 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |